FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966832362> ?p ?o ?g. }

• W1966832362 endingPage "382" @default.
• W1966832362 startingPage "378" @default.
• W1966832362 abstract "More patients who are receiving therapy with a left ventricular assist device (LVAD) also have an implantable cardioverter-defibrillator (ICD). The aim of the present study was to describe the outcomes and device interactions of simultaneous therapy with an ICD and a LVAD. We evaluated 76 patients with class IV heart failure (age 52 ± 12 years, left ventricular ejection fraction 0.13 ± 0.05%, 88% men, 61% nonischemic cardiomyopathy) with both an ICD and a LVAD. The median follow-up with both devices was 156 days. A LVAD with a pulsatile and continuous flow pump was used in 53 (70%) and 23 (30%) patients, respectively. Of the 76 patients, 12 (16%) received a total of 54 ICD therapies. Of the ICD therapies, 88% were appropriate. Of the 76 patients, 55 (72%) underwent heart transplantation a median of 146 days after LVAD implantation. Twelve patients (16%) died during simultaneous ICD and LVAD therapy. Interactions between the LVAD and ICD occurred in 2 patients (2.7%) with continuous flow pumps (HeartMate II). In both cases, telemetry failure occurred after LVAD implantation with 2 different models of ICDs from the same manufacturer. No ICD therapies occurred because of device-related interactions. In conclusion, simultaneous ICD and LVAD therapy in patients with severe congestive heart failure is safe and clinically feasible. Interactions between the devices are uncommon and appear limited to specific models of ICDs. More patients who are receiving therapy with a left ventricular assist device (LVAD) also have an implantable cardioverter-defibrillator (ICD). The aim of the present study was to describe the outcomes and device interactions of simultaneous therapy with an ICD and a LVAD. We evaluated 76 patients with class IV heart failure (age 52 ± 12 years, left ventricular ejection fraction 0.13 ± 0.05%, 88% men, 61% nonischemic cardiomyopathy) with both an ICD and a LVAD. The median follow-up with both devices was 156 days. A LVAD with a pulsatile and continuous flow pump was used in 53 (70%) and 23 (30%) patients, respectively. Of the 76 patients, 12 (16%) received a total of 54 ICD therapies. Of the ICD therapies, 88% were appropriate. Of the 76 patients, 55 (72%) underwent heart transplantation a median of 146 days after LVAD implantation. Twelve patients (16%) died during simultaneous ICD and LVAD therapy. Interactions between the LVAD and ICD occurred in 2 patients (2.7%) with continuous flow pumps (HeartMate II). In both cases, telemetry failure occurred after LVAD implantation with 2 different models of ICDs from the same manufacturer. No ICD therapies occurred because of device-related interactions. In conclusion, simultaneous ICD and LVAD therapy in patients with severe congestive heart failure is safe and clinically feasible. Interactions between the devices are uncommon and appear limited to specific models of ICDs." @default.
• W1966832362 created "2016-06-24" @default.
• W1966832362 creator A5027609723 @default.
• W1966832362 creator A5033413319 @default.
• W1966832362 creator A5033504758 @default.
• W1966832362 creator A5034043295 @default.
• W1966832362 creator A5036439529 @default.
• W1966832362 creator A5037739106 @default.
• W1966832362 creator A5041339841 @default.
• W1966832362 creator A5044636344 @default.
• W1966832362 creator A5046059574 @default.
• W1966832362 creator A5050364345 @default.
• W1966832362 creator A5053447209 @default.
• W1966832362 creator A5066058824 @default.
• W1966832362 creator A5071672109 @default.
• W1966832362 creator A5073665379 @default.
• W1966832362 creator A5077905888 @default.
• W1966832362 creator A5080972012 @default.
• W1966832362 creator A5084156006 @default.
• W1966832362 date "2010-02-01" @default.
• W1966832362 modified "2023-09-28" @default.
• W1966832362 title "Simultaneous Use of Implantable Cardioverter-Defibrillators and Left Ventricular Assist Devices in Patients With Severe Heart Failure" @default.
• W1966832362 cites W1981964073 @default.
• W1966832362 cites W1995525695 @default.
• W1966832362 cites W1995876837 @default.
• W1966832362 cites W2006414288 @default.
• W1966832362 cites W2024792352 @default.
• W1966832362 cites W2033743206 @default.
• W1966832362 cites W2047951659 @default.
• W1966832362 cites W2063425371 @default.
• W1966832362 cites W2075175982 @default.
• W1966832362 cites W2078123225 @default.
• W1966832362 cites W2080796056 @default.
• W1966832362 cites W2085988975 @default.
• W1966832362 cites W2095676038 @default.
• W1966832362 cites W2116738159 @default.
• W1966832362 cites W2118141608 @default.
• W1966832362 cites W2134275327 @default.
• W1966832362 cites W2153424944 @default.
• W1966832362 cites W2169138421 @default.
• W1966832362 cites W2329246899 @default.
• W1966832362 doi "https://doi.org/10.1016/j.amjcard.2009.09.044" @default.
• W1966832362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20102952" @default.
• W1966832362 hasPublicationYear "2010" @default.
• W1966832362 type Work @default.
• W1966832362 sameAs 1966832362 @default.
• W1966832362 citedByCount "47" @default.
• W1966832362 countsByYear W19668323622012 @default.
• W1966832362 countsByYear W19668323622013 @default.
• W1966832362 countsByYear W19668323622014 @default.
• W1966832362 countsByYear W19668323622015 @default.
• W1966832362 countsByYear W19668323622016 @default.
• W1966832362 countsByYear W19668323622017 @default.
• W1966832362 countsByYear W19668323622018 @default.
• W1966832362 countsByYear W19668323622019 @default.
• W1966832362 countsByYear W19668323622020 @default.
• W1966832362 countsByYear W19668323622021 @default.
• W1966832362 countsByYear W19668323622022 @default.
• W1966832362 countsByYear W19668323622023 @default.
• W1966832362 crossrefType "journal-article" @default.
• W1966832362 hasAuthorship W1966832362A5027609723 @default.
• W1966832362 hasAuthorship W1966832362A5033413319 @default.
• W1966832362 hasAuthorship W1966832362A5033504758 @default.
• W1966832362 hasAuthorship W1966832362A5034043295 @default.
• W1966832362 hasAuthorship W1966832362A5036439529 @default.
• W1966832362 hasAuthorship W1966832362A5037739106 @default.
• W1966832362 hasAuthorship W1966832362A5041339841 @default.
• W1966832362 hasAuthorship W1966832362A5044636344 @default.
• W1966832362 hasAuthorship W1966832362A5046059574 @default.
• W1966832362 hasAuthorship W1966832362A5050364345 @default.
• W1966832362 hasAuthorship W1966832362A5053447209 @default.
• W1966832362 hasAuthorship W1966832362A5066058824 @default.
• W1966832362 hasAuthorship W1966832362A5071672109 @default.
• W1966832362 hasAuthorship W1966832362A5073665379 @default.
• W1966832362 hasAuthorship W1966832362A5077905888 @default.
• W1966832362 hasAuthorship W1966832362A5080972012 @default.
• W1966832362 hasAuthorship W1966832362A5084156006 @default.
• W1966832362 hasConcept C126322002 @default.
• W1966832362 hasConcept C164705383 @default.
• W1966832362 hasConcept C2775932942 @default.
• W1966832362 hasConcept C2777093960 @default.
• W1966832362 hasConcept C2777795826 @default.
• W1966832362 hasConcept C2778198053 @default.
• W1966832362 hasConcept C2778774980 @default.
• W1966832362 hasConcept C2778797674 @default.
• W1966832362 hasConcept C2778849806 @default.
• W1966832362 hasConcept C2779326848 @default.
• W1966832362 hasConcept C71924100 @default.
• W1966832362 hasConcept C78085059 @default.
• W1966832362 hasConceptScore W1966832362C126322002 @default.
• W1966832362 hasConceptScore W1966832362C164705383 @default.
• W1966832362 hasConceptScore W1966832362C2775932942 @default.
• W1966832362 hasConceptScore W1966832362C2777093960 @default.
• W1966832362 hasConceptScore W1966832362C2777795826 @default.
• W1966832362 hasConceptScore W1966832362C2778198053 @default.
• W1966832362 hasConceptScore W1966832362C2778774980 @default.
• W1966832362 hasConceptScore W1966832362C2778797674 @default.
• W1966832362 hasConceptScore W1966832362C2778849806 @default.

• next